Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 16/20 | 0.59 |
| ▸ | DPP8 | Q6V1X1 | 4/20 | 0.59 |
| ▸ | DPP9 | Q86TI2 | 3/20 | 0.59 |
| ▸ | FAP | Q12884 | 1/20 | 0.59 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.43 |
| ▸ | GLMN | Q92990 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4450998 | 1.00 | DPP4 (0.59) | DPP4DPP8DPP9FAPDPP7 | |
| SCHEMBL12354533 | 0.85 | DPP4 (0.60) | DPP4DPP8DPP9FAPDPP7 | |
| SCHEMBL1038132 | 0.76 | DPP4 (0.73) | DPP4DPP8DPP9FAPDPP7 | |
| SCHEMBL30730737 | 0.76 | DPP4 (0.73) | DPP4DPP8DPP9FAPDPP7 | |
| Vildagliptin SCHEMBL16823370 | 0.74 | DPP4 (1.00) | DPP4DPP8DPP9FAP | |
| Vildagliptin SCHEMBL665401 | 0.74 | DPP4 (1.00) | DPP4DPP8DPP9FAP | |
| Vildagliptin SCHEMBL671629 | 0.74 | DPP4 (1.00) | DPP4DPP8DPP9FAP | |
| Vildagliptin SCHEMBL16579 | 0.74 | DPP4 (1.00) | DPP4DPP8DPP9FAP | |
| Vildagliptin SCHEMBL10031674 | 0.74 | DPP4 (1.00) | DPP4DPP8DPP9FAP | |
| Vildagliptin SCHEMBL665400 | 0.74 | DPP4 (1.00) | DPP4DPP8DPP9FAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1917001-A2 | PHARMACEUTICAL COMPOSITION COMPRISING A DPP-IV INHIBITOR | F.HOFFMANN-LA ROCHE AG (CH) | 2008-05-07 | — | — | EP | disclosed |
| WO-2007017423-A2 | PHARMACEUTICAL COMPOSITION COMPRISING A DPP-IV INHIBITOR | F. HOFFMANN-LA ROCHE AG (CH) | 2007-02-15 | — | — | WO | disclosed |